J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
2,192.60
-22.55 (-1.02%)
At close: Jun 16, 2026
BOM:506943 Revenue
In the fiscal year ending March 31, 2026, J. B. Chemicals & Pharmaceuticals had annual revenue of 41.48B INR with 5.87% growth. J. B. Chemicals & Pharmaceuticals had revenue of 9.04B in the quarter ending March 31, 2026, a decrease of -4.77%.
Revenue
41.48B
Revenue Growth
+5.87%
P/S Ratio
8.49
Revenue / Employee
7.40M
Employees
5,602
Market Cap
352.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 41.48B | 2.30B | 5.87% |
| Mar 31, 2025 | 39.18B | 4.34B | 12.45% |
| Mar 31, 2024 | 34.84B | 3.35B | 10.63% |
| Mar 31, 2023 | 31.49B | 7.25B | 29.91% |
| Mar 31, 2022 | 24.24B | 3.82B | 18.69% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 335.93B |
| Lupin | 279.58B |
| Jubilant Pharmova | 82.80B |
| Abbott India | 69.29B |
| Granules India | 53.66B |
| GlaxoSmithKline Pharmaceuticals | 38.22B |
| Viyash Scientific | 34.20B |
| AstraZeneca Pharma India | 22.76B |
J. B. Chemicals & Pharmaceuticals News
- 4 days ago - JB Chemicals executive vice president Bhushan Sachdev resigns - Business Upturn
- 20 days ago - JB Chemicals & Pharmaceuticals announces 50th AGM via video conference - Business Upturn
- 22 days ago - JB Chemicals reports 35% of turnover from exports in FY26 - Business Upturn
- 5 weeks ago - J. B. Chemicals & Pharmaceuticals Transcript: Q4 25/26 - Transcripts
- 5 weeks ago - J. B. Chemicals & Pharmaceuticals Quarterly report: Q4 2026 - Filings
- 5 weeks ago - J. B. Chemicals & Pharmaceuticals Annual report: Q4 2026 - Filings
- 5 weeks ago - JB Chemicals reports Rs 904 crore revenue in Q4 FY26; net profit declines by 30% - Business Upturn
- 2 months ago - JB Chemicals calls shareholders' meeting under National Company Law Tribunal order - Business Upturn